Biovail
Biovail officials detail recent developments
Published in Health Business Week, May 25th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Biovail.
Report 1: Biovail Corporation (NYSE, TSX: BVF) and Depomed, Inc. (NASDAQ: DEPO) announced today that the companies have entered into an agreement that provides Biovail with access to Depomed's proprietary AcuForm (TM) drug-delivery technology for the development of up to two Biovail products.
Under the terms of the agreement, Depomed has granted Biovail Laboratories International SRL, a subsidiary of Biovail, an option to license Depomed's AcuForm (TM) technology to develop...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-05-25)
More Articles from Health Business Week
- AARP
AARP Rolls Up Their Sleeves Nationwide, Gives Back to Local Communities - Abbott
Abbott Highlights Strong Performance in Corporate Social Responsibility in 2006 Global Citizenship Report - Abraxis BioScience, Inc.
Abraxis BioScience Reports First Quarter 2007 Revenue of $212.2 Million Versus $144.5 Million in Prior Year Period - Access Communications, LLC
Access Communications, LLC, Enters New Era of Growth - Adaptis
Adaptis Announces Operations Center Promotions, New Openings - Adverse Drug Reactions
CollaGenex Pharmaceuticals Discontinues 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
